US Stock MarketDetailed Quotes

SCNI Scinai Immunotherapeutics

Watchlist

3.245
-0.015-0.46%

Close Dec 4 16:00 ET

2.77MMarket Cap1.35P/E (TTM)

Scinai Immunotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

168K

284K

Operating revenue

--168K

--284K

--0

Cost of revenue

417K

Gross profit

-249K

Operating expense

3.28%2.17M

-28.21%1.86M

-39.49%1.93M

-12.25%9.71M

-39.68%1.82M

-2.73%2.1M

-20.47%2.6M

21.84%3.19M

1.83%11.06M

-12.26%3.02M

Selling and administrative expenses

-21.07%764K

-54.51%519K

-59.36%484K

-14.94%4.51M

-24.12%1.21M

0.10%968K

-11.48%1.14M

-17.98%1.19M

-30.54%5.3M

-30.38%1.59M

Research and development costs

24.07%1.41M

-16.09%1.22M

-21.40%1.57M

-9.63%5.21M

-56.28%627K

-5.03%1.13M

-26.34%1.45M

71.54%2M

77.44%5.77M

22.00%1.43M

Other operating expenses

----

---124K

---9K

----

Operating profit

-15.13%-2.42M

21.89%-2.03M

39.49%-1.93M

12.25%-9.71M

39.68%-1.82M

2.73%-2.1M

20.47%-2.6M

-21.84%-3.19M

-1.83%-11.06M

12.26%-3.02M

Net non-operating interest income expense

147.17%12.88M

74.72%-295K

29.79%-231K

-96.20%115K

16.89%-3.6M

-24.93%5.21M

-516.79%-1.17M

-335.00%-329K

-3.60%3.03M

-190.16%-4.33M

Non-operating interest income

183.34%14.76M

----

-95.97%123K

---3.59M

--5.21M

----

-3.20%3.05M

----

Non-operating interest expense

--1.88M

--295K

-29.79%231K

----

--329K

----

Total other finance cost

----

-61.90%8K

----

516.79%1.17M

----

133.33%21K

--7.38M

Other net income (expense)

38.30%3.09M

558.93%2.24M

Gain on sale of security

----

38.30%3.09M

----

558.93%2.24M

----

Income before tax

236.50%10.46M

38.28%-2.32M

38.58%-2.16M

-12.15%-6.5M

54.46%-2.33M

-34.97%3.11M

-26.11%-3.76M

-42.02%-3.52M

29.37%-5.8M

-688.08%-5.12M

Income tax

Net income

236.50%10.46M

38.28%-2.32M

38.58%-2.16M

-12.15%-6.5M

54.46%-2.33M

-34.97%3.11M

-26.11%-3.76M

-42.02%-3.52M

29.37%-5.8M

-688.08%-5.12M

Net income continuous Operations

236.50%10.46M

38.28%-2.32M

38.58%-2.16M

-12.15%-6.5M

54.46%-2.33M

-34.97%3.11M

-26.11%-3.76M

-42.02%-3.52M

29.37%-5.8M

-688.08%-5.12M

Minority interest income

Net income attributable to the parent company

236.50%10.46M

38.28%-2.32M

38.58%-2.16M

-12.15%-6.5M

54.46%-2.33M

-34.97%3.11M

-26.11%-3.76M

-42.02%-3.52M

29.37%-5.8M

-688.08%-5.12M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

236.50%10.46M

38.28%-2.32M

38.58%-2.16M

-12.15%-6.5M

54.46%-2.33M

-34.97%3.11M

-26.11%-3.76M

-42.02%-3.52M

29.37%-5.8M

-688.08%-5.12M

Basic earnings per share

5.00%8.4

66.67%-4

60.00%-16

77.78%-8

-80.00%8

25.00%-12

0.00%-12

50.00%-40

-101.24%-36

Diluted earnings per share

5.00%8.4

66.67%-4

60.00%-16

77.78%-8

-80.00%8

25.00%-12

0.00%-12

50.00%-40

-101.24%-36

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	168K	284K	0	0	0	0	0	0	0	0
Operating revenue	--168K	--284K	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue	417K					0
Gross profit	-249K					0
Operating expense	3.28%2.17M	-28.21%1.86M	-39.49%1.93M	-12.25%9.71M	-39.68%1.82M	-2.73%2.1M	-20.47%2.6M	21.84%3.19M	1.83%11.06M	-12.26%3.02M
Selling and administrative expenses	-21.07%764K	-54.51%519K	-59.36%484K	-14.94%4.51M	-24.12%1.21M	0.10%968K	-11.48%1.14M	-17.98%1.19M	-30.54%5.3M	-30.38%1.59M
Research and development costs	24.07%1.41M	-16.09%1.22M	-21.40%1.57M	-9.63%5.21M	-56.28%627K	-5.03%1.13M	-26.34%1.45M	71.54%2M	77.44%5.77M	22.00%1.43M
Other operating expenses	----	----	---124K	---9K	----	----	----	----	----	----
Operating profit	-15.13%-2.42M	21.89%-2.03M	39.49%-1.93M	12.25%-9.71M	39.68%-1.82M	2.73%-2.1M	20.47%-2.6M	-21.84%-3.19M	-1.83%-11.06M	12.26%-3.02M
Net non-operating interest income expense	147.17%12.88M	74.72%-295K	29.79%-231K	-96.20%115K	16.89%-3.6M	-24.93%5.21M	-516.79%-1.17M	-335.00%-329K	-3.60%3.03M	-190.16%-4.33M
Non-operating interest income	183.34%14.76M	----	----	-95.97%123K	---3.59M	--5.21M	----	----	-3.20%3.05M	----
Non-operating interest expense	--1.88M	--295K	-29.79%231K	----	----	----	----	--329K	----	----
Total other finance cost	----	----	----	-61.90%8K	----	----	516.79%1.17M	----	133.33%21K	--7.38M
Other net income (expense)				38.30%3.09M					558.93%2.24M
Gain on sale of security	----	----	----	38.30%3.09M	----	----	----	----	558.93%2.24M	----
Income before tax	236.50%10.46M	38.28%-2.32M	38.58%-2.16M	-12.15%-6.5M	54.46%-2.33M	-34.97%3.11M	-26.11%-3.76M	-42.02%-3.52M	29.37%-5.8M	-688.08%-5.12M
Income tax
Net income	236.50%10.46M	38.28%-2.32M	38.58%-2.16M	-12.15%-6.5M	54.46%-2.33M	-34.97%3.11M	-26.11%-3.76M	-42.02%-3.52M	29.37%-5.8M	-688.08%-5.12M
Net income continuous Operations	236.50%10.46M	38.28%-2.32M	38.58%-2.16M	-12.15%-6.5M	54.46%-2.33M	-34.97%3.11M	-26.11%-3.76M	-42.02%-3.52M	29.37%-5.8M	-688.08%-5.12M
Minority interest income
Net income attributable to the parent company	236.50%10.46M	38.28%-2.32M	38.58%-2.16M	-12.15%-6.5M	54.46%-2.33M	-34.97%3.11M	-26.11%-3.76M	-42.02%-3.52M	29.37%-5.8M	-688.08%-5.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	236.50%10.46M	38.28%-2.32M	38.58%-2.16M	-12.15%-6.5M	54.46%-2.33M	-34.97%3.11M	-26.11%-3.76M	-42.02%-3.52M	29.37%-5.8M	-688.08%-5.12M
Basic earnings per share	5.00%8.4	66.67%-4	66.67%-4	60.00%-16	77.78%-8	-80.00%8	25.00%-12	0.00%-12	50.00%-40	-101.24%-36
Diluted earnings per share	5.00%8.4	66.67%-4	66.67%-4	60.00%-16	77.78%-8	-80.00%8	25.00%-12	0.00%-12	50.00%-40	-101.24%-36
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data